nodes	percent_of_prediction	percent_of_DWPC	metapath
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00538	0.00538	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.00536	0.00536	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00522	0.00522	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0052	0.0052	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00519	0.00519	CbGpPWpGaD
Metixene—CHRM5—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00519	0.00519	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00518	0.00518	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.00517	0.00517	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00515	0.00515	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.0051	0.0051	CbGpPWpGaD
Metixene—HTR2C—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.0051	0.0051	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00508	0.00508	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.00506	0.00506	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00505	0.00505	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00488	0.00488	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00484	0.00484	CbGpPWpGaD
Metixene—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00465	0.00465	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00464	0.00464	CbGpPWpGaD
Metixene—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00464	0.00464	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00463	0.00463	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00456	0.00456	CbGpPWpGaD
Metixene—CHRM4—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00451	0.00451	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00447	0.00447	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00446	0.00446	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00441	0.00441	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.0044	0.0044	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00439	0.00439	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00432	0.00432	CbGpPWpGaD
Metixene—HTR2C—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00423	0.00423	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00414	0.00414	CbGpPWpGaD
Metixene—CHRM1—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.00405	0.00405	CbGpPWpGaD
Metixene—CHRM3—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.00404	0.00404	CbGpPWpGaD
Metixene—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00401	0.00401	CbGpPWpGaD
Metixene—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.004	0.004	CbGpPWpGaD
Metixene—CHRM2—Regulation of Actin Cytoskeleton—FN1—focal segmental glomerulosclerosis	0.004	0.004	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00398	0.00398	CbGpPWpGaD
Metixene—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00396	0.00396	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00394	0.00394	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00394	0.00394	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00392	0.00392	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00388	0.00388	CbGpPWpGaD
Metixene—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00378	0.00378	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00372	0.00372	CbGpPWpGaD
Metixene—CHRM1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00365	0.00365	CbGpPWpGaD
Metixene—CHRM3—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00364	0.00364	CbGpPWpGaD
Metixene—CHRM4—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00359	0.00359	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00344	0.00344	CbGpPWpGaD
Metixene—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00344	0.00344	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00343	0.00343	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.0034	0.0034	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00339	0.00339	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00339	0.00339	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00337	0.00337	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00336	0.00336	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00329	0.00329	CbGpPWpGaD
Metixene—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00327	0.00327	CbGpPWpGaD
Metixene—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00326	0.00326	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00315	0.00315	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	0.00315	0.00315	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00303	0.00303	CbGpPWpGaD
Metixene—CHRM2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.003	0.003	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00291	0.00291	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00291	0.00291	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00288	0.00288	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00287	0.00287	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00285	0.00285	CbGpPWpGaD
Metixene—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.0028	0.0028	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00275	0.00275	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00273	0.00273	CbGpPWpGaD
Metixene—CHRM4—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00273	0.00273	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0027	0.0027	CbGpPWpGaD
Metixene—CHRM1—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	0.00265	0.00265	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00262	0.00262	CbGpPWpGaD
Metixene—CHRM5—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00262	0.00262	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00261	0.00261	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00261	0.00261	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00259	0.00259	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00258	0.00258	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00258	0.00258	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00257	0.00257	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0025	0.0025	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00248	0.00248	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00248	0.00248	CbGpPWpGaD
Metixene—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00242	0.00242	CbGpPWpGaD
Metixene—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00241	0.00241	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0024	0.0024	CbGpPWpGaD
Metixene—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00239	0.00239	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00237	0.00237	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0023	0.0023	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00224	0.00224	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00223	0.00223	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00222	0.00222	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00221	0.00221	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00219	0.00219	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Metixene—HTR2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00213	0.00213	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00203	0.00203	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00202	0.00202	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.002	0.002	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00199	0.00199	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00194	0.00194	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00193	0.00193	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00193	0.00193	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00192	0.00192	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00192	0.00192	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0019	0.0019	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Metixene—CHRM1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00184	0.00184	CbGpPWpGaD
Metixene—CHRM3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00184	0.00184	CbGpPWpGaD
Metixene—CHRM2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00181	0.00181	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00176	0.00176	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00175	0.00175	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00175	0.00175	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00174	0.00174	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00173	0.00173	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00172	0.00172	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0017	0.0017	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00169	0.00169	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00161	0.00161	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00156	0.00156	CbGpPWpGaD
Metixene—CHRM4—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00153	0.00153	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Metixene—CHRM5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Metixene—CHRM4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.0014	0.0014	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00139	0.00139	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Metixene—CHRM5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00133	0.00133	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00132	0.00132	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Metixene—CHRM3—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00128	0.00128	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Metixene—HTR2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00119	0.00119	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Metixene—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Metixene—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Metixene—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Metixene—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Metixene—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Metixene—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00102	0.00102	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00102	0.00102	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.001	0.001	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000998	0.000998	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000968	0.000968	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000956	0.000956	CbGpPWpGaD
Metixene—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000945	0.000945	CbGpPWpGaD
Metixene—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000942	0.000942	CbGpPWpGaD
Metixene—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000933	0.000933	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000927	0.000927	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000919	0.000919	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000917	0.000917	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000878	0.000878	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000868	0.000868	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000865	0.000865	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000857	0.000857	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000828	0.000828	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000794	0.000794	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000793	0.000793	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000791	0.000791	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000783	0.000783	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000779	0.000779	CbGpPWpGaD
Metixene—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	0.000778	0.000778	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000765	0.000765	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000756	0.000756	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000733	0.000733	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000716	0.000716	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000673	0.000673	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000671	0.000671	CbGpPWpGaD
Metixene—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	0.000666	0.000666	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000664	0.000664	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000653	0.000653	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000651	0.000651	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000647	0.000647	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000644	0.000644	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000637	0.000637	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000618	0.000618	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000616	0.000616	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00061	0.00061	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00061	0.00061	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000597	0.000597	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000559	0.000559	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000557	0.000557	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000551	0.000551	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000516	0.000516	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000514	0.000514	CbGpPWpGaD
Metixene—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	0.000511	0.000511	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000509	0.000509	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000497	0.000497	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000488	0.000488	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000467	0.000467	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000429	0.000429	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000428	0.000428	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000424	0.000424	CbGpPWpGaD
Metixene—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000402	0.000402	CbGpPWpGaD
Metixene—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000385	0.000385	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000381	0.000381	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000329	0.000329	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000328	0.000328	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000325	0.000325	CbGpPWpGaD
Metixene—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000314	0.000314	CbGpPWpGaD
Metixene—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000271	0.000271	CbGpPWpGaD
Metixene—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00027	0.00027	CbGpPWpGaD
Metixene—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000268	0.000268	CbGpPWpGaD
